We use cookies to offer you a better browsing experience, analyze site traffic, personalize content. Read about how we use Cookies, along with our Privacy Policy and Terms of Use. If you continue to use this site, you consent to our use of cookies.

I agree

Search filter

Back to news < Previous Next >

News / 26th March 2018

Share

Moving on from Mallinckrodt: Curium eyes $650 million in radiopharmaceuticals sales

Curium North American CEO Dan Brague recently offered St. Louis Business Journal an insight into Curium journey, the state of nuclear medicine and the company’s vision for the future.

Read the St. Louis Business Journal’s article here.

Filter by

Moving on from Mallinckrodt: Curium eyes $650 million in radiopharmaceuticals sales